pms-Fluoxetine Indications/Uses

Adults: Depression: pms-FLUOXETINE (fluoxetine hydrochloride) is indicated for the symptomatic relief of Major Depressive Disorder (MDD).
Bulimia Nervosa: Fluoxetine has been shown to significantly decrease binge-eating and purging activity when compared with placebo treatment.
Obsessive-Compulsive Disorder: pms-FLUOXETINE is indicated for the symptomatic treatment of obsessive-compulsive disorder (OCD).
The obsessions or compulsions must be experienced as intrusive, markedly distressing, time consuming, or interfering significantly with the person's social or occupational functioning.
The efficacy of fluoxetine in hospitalized patients has not been adequately studied.
Long-term use of fluoxetine: The effectiveness of fluoxetine in long-term use in bulimia nervosa (i.e. for more than 16 weeks) and in obsessive-compulsive disorder (i.e. for more than 13 weeks) has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use pms-FLUOXETINE in these indications for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.
Geriatrics (≥60 years of age): Evidence from clinical studies and experience suggests that use in the geriatric population may be associated with differences in safety or effectiveness, and a brief discussion can be found in Special Patient Populations: Use in the Elderly under Dosage & Administration; Use in Elderly under Precautions.
Pediatrics (<18 years of age): pms-FLUOXETINE is not indicated for use in patients below the age of 18 years. See General: Potential Association with Behavioural and Emotional Changes, Including Self-Harm under Precautions; see also Clinical Trial Adverse Drug Reactions: Special Populations: Pediatrics (<18 years of age): Potential for Effects on Growth in Pediatric Patients under Adverse Reactions.